Table: begin end state 1 32 signal peptide 33 274 non-cytoplasmic 275 299 transmembrane 300 307 cytoplasmic 308 324 transmembrane 325 329 non-cytoplasmic 330 350 transmembrane 351 361 cytoplasmic 362 380 transmembrane 381 410 non-cytoplasmic 411 430 transmembrane 431 457 cytoplasmic 458 480 transmembrane 481 495 non-cytoplasmic 496 520 transmembrane 521 527 cytoplasmic 528 548 transmembrane 549 563 non-cytoplasmic
Input: >WP_015817423.1 NCBI__GCF_000023025.1:WP_015817423.1 MKYTKSTAILLLVSILVMATHSFAQAPVAEAQEESVTAEETVGSEATALQFETLVSQLTQ RSFSKKAKVIEQLTQIKDPRILPTLKVMLDGDLYYQKADDQIVTVQNAADGVQPTSVITG QLLALVGKRDVKKVTINNTLRRELRKAIAVLELSDVDSDVRRESARNLIKSPDADLRDTI AQSAASETDNTVKHLLEVALALIDIDSADPSLRLGATRKLGGAVEPEAVAVLKRLAQRNE QGQFVEPDNAVAKLAEERLKSVETKLSFFKFSENLLFGLSLGSVLLLAAIGLAITFGVMG VINMAHGEMIMLGAYTTFAIQQLFPSLIDISLFLAIPAAFLVSGSAGVLIERLVIRHLYG RPLDTLLATFGISLILQQAVRTYRANNVPVVTPDWMSGSWLINGAMSVTLNRVYILLFAL FVLFMLALLLRKTLVGLQMRAVTQNRAMATSMGIRSNWVDALTFGLGSGIAGIAGVALSQ ITNVGPNLGQSYIIDSFMVVVFGGVGNLLGTFVGAMSLGVVNKFLEPVTGAVIGKIIVLI FIILFIQWRPRGLFALKGRFVED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server